ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3115

Reconsidering the Juvenile Idiopathic Arthritis Core Set: How Patients and Caregivers Define Disease Activity

Jennifer R. Horonjeff1, Susan Thornhill2, Daniel B. Horton3, Jennifer N. Stinson4, Anjali Fortna5, Stephanie Luca6, Arlene Vinci7, Laura C. Marrow8, Emily L. Creek7, Meredith Riebschleger9, Alessandro Consolaro10, Jane Munro11, Vibeke Strand12, Clifton Bingham III13 and Esi Morgan14, 1Rheumatology, Columbia University Medical Center, New York, NY, 2Thornhill Associates, Hermosa Beach, CA, 3Pediatrics, Division of Pediatric Rheumatology, Rutgers Robert Wood Johnson Medical School, Rutgers Biomedical and Health Sciences, New Brunswick, NJ, 4Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 5Columbia University Medical Center, New York, NY, 6The Hospital for Sick Children, Toronto, ON, Canada, 7Consumer Health, Arthritis Foundation, Atlanta, GA, 8Arthritis Foundation, Atlanta, GA, 9Pediatric Rheumatology & Health Services Research, University of Michigan, Ann Arbor, MI, 10Pediatria II - Reumatologia, PRINTO, Istituto Giannina Gaslini, Genoa, Italy, 11Rheumatology, Royal Children's Hospital, Parkville, Australia, 12Stanford University School of Medicine, Palo Alto, CA, 13Divisions of Rheumatology and Allergy, Department of Medicine, Johns Hopkins University, Johns Hopkins University, Baltimore, MD, 14Pediatric Rheumatology, Cincinnati Children's Hospital, Cincinnati, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: juvenile idiopathic arthritis (JIA), Outcome measures, patient engagement, patient outcomes and pediatrics

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, November 16, 2016

Title: ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: The current JIA Core Set (ACR Pediatric 30) contains items that should be assessed in clinical trials for children with JIA. It was developed in 1997 without subsequent update. A shortcoming of the existing Core Set is the lack of patient/caregiver input in its development. The OMERACT JIA Core Set Group formed in 2015 as an international initiative to revise the existing Core Set with relevant patient/caregiver input. The aim of the current study, as part of the larger initiative, was to conduct focus groups to: 1) develop a comprehensive list of potential patient/caregiver outcome domains, 2) define the concept(s) represented by each domain, and 3) begin to prioritize these domains.

Methods: Patient and caregivers from North America participated in virtual focus groups (VFGs) about their experiences related to JIA. The VFGs utilized online discussion boards instead of in-person focus groups in order to accommodate more participants from diverse geographic regions, facilitate unrestricted sharing, and be efficient and cost-effective. Two sets of VFGs were performed: 1) caregivers and 2) adolescents and young adults with JIA. Eligibility was based on self-reported diagnosis of JIA and prior or current experience of JIA disease inactivity (>3 months). A qualitative researcher conducted the VFGs, which consisted of a 3-day online discussion board per group. Discussion guides sought to elucidate the impact of JIA on physical, mental and social health, and the perceived differences between active and inactive JIA. Participants answered questions individually and then could comment on others’ responses. Transcripts were coded into domains with respect to OMERACT Core Areas and analyzed using NVivo 10.

Results: The caregiver VFG was split based on the age of their children: <15 years (n=10), and >15 years (n=10). The patient VFG was split into ages 15-17 (n=11), and 18-24 (n=13). Each group was diverse with respect to geography and categories of JIA, and included patients with active and inactive disease at the time of study. Participants discussed their experiences with JIA, life impact, resource use, pathophysiological manifestations, and adverse effects of JIA and its treatment. Data analysis revealed unique domains not represented in the current Core Set. Patients identified various psychosocial impacts of JIA and how it impacted participation in activities with their peers, school and/or job. Caregivers of younger children expressed fear for the future and unknown manifestations of JIA. Caregivers of older children identified the impact JIA had on the family and their child’s participation in activities. Patients and caregivers characterized disease inactivity as the absence of pain, stiffness and swelling, increased activity participation, and improved mood and sleep quality.

Conclusion: The VFG format helped elicit concepts important to distinct and diverse groups of stakeholders affected by JIA. The current JIA Core Set lacks the patient/caregiver-centered domains identified in this study. Future efforts will perform VFGs in other geographic areas (Europe, Australia) and develop a model of the patient/caregiver experience of JIA that will inform the ongoing effort to expand the JIA Core Set.


Disclosure: J. R. Horonjeff, None; S. Thornhill, None; D. B. Horton, None; J. N. Stinson, None; A. Fortna, None; S. Luca, None; A. Vinci, None; L. C. Marrow, None; E. L. Creek, None; M. Riebschleger, None; A. Consolaro, None; J. Munro, None; V. Strand, None; C. Bingham III, None; E. Morgan, None.

To cite this abstract in AMA style:

Horonjeff JR, Thornhill S, Horton DB, Stinson JN, Fortna A, Luca S, Vinci A, Marrow LC, Creek EL, Riebschleger M, Consolaro A, Munro J, Strand V, Bingham C III, Morgan E. Reconsidering the Juvenile Idiopathic Arthritis Core Set: How Patients and Caregivers Define Disease Activity [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/reconsidering-the-juvenile-idiopathic-arthritis-core-set-how-patients-and-caregivers-define-disease-activity/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reconsidering-the-juvenile-idiopathic-arthritis-core-set-how-patients-and-caregivers-define-disease-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology